- Articles by topic
- Articles by date
Wave 2 of our pharmacy benefit migration is underway; good progress is reported.
Synchronization means personalized data that will help engage members faster for improved health, a simpler care experience and lower total costs.
Drugs exposed to excessive heat or cold in transit can put patients at risk. But OptumRx packaging not only meets but exceeds international shipping standards.
Please take a few minutes to review our wide array of informative articles.
We watch for new drug launches, as well as on medications expected to gain approval in the next several months.
In this issue
Please contact your UnitedHealthcare representative or broker.
Greetings and welcome to Pharmacy InFocus.
Spring is having a hard time getting a foothold for those of us here in the upper Midwest. Still it signals that we are nearing the end of the second quarter and with that a new issue of Pharmacy InFocus. Here are some highlights:
Our migration process is now moving into high gear, as millions of members and tens of thousands of client groups move onto our internal systems. Our Migration Update article will add some detail around this progress.
I’m especially pleased to bring you our lead article for this issue. This is a white paper treatment of a joint UnitedHealthcare/OptumRx study on the positive results our Specialty Pharmacy Program had for kidney transplant patients. The white paper outlines how patients who used our Specialty program experienced better care outcomes and lower costs compared with those who used traditional retail pharmacies.
Next, we continue to define and track results of our early Synchronization approach; how bringing together our people, systems and data are starting to have a meaningful impact on the quality and efficiency of the health care experience.
This issue also features a topic that should be on everyone’s mind: the relatively unknown risks that stem from shipping sensitive biologic medicines via mail. We explore the background of this complex problem, plus what UnitedHealthcare is doing about it.
Finally, be sure to see our latest Drug Pipeline report for a look at some of the new and pending medications that could have an impact on your pharmacy costs.
Best wishes for a green and warm spring. I hope you enjoy this issue of Pharmacy InFocus.
As always, please let us know what you think by using the “Feedback” function on the front page.